Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

(CSE: LOBE )

0.0400 UNCHANGED
Streaming Delayed Price Updated: 9:30 AM EDT, Mar 24, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 25,400
Open 0.0400
Bid (Size) 0.0350 (402,000)
Ask (Size) 0.0400 (23,000)
Prev. Close 0.0400
Today's Range 0.0400 - 0.0400
52wk Range 0.0100 - 0.2900
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Chronic Cluster Headaches No More: The Promise Of Lobe Sciences' At-Home Psychedelic Treatments Without The Trip!
By Richard Dal Monte 
Via TheNewswire.com
Psychedelic-Derived Medicines for Neurologic Conditions Fueling Large Revenue Growth in Projected $4 Billion Dollar Industry
EQNX::TICKER_START (OTCQB:LOBEF),(NASDAQ:ATAI),(NASDAQ:CMPS),(NYSE:CYBN),(NASDAQ:MNMD) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Economy
Exposures Supply Chain

Performance

YTD
-20.00%
-20.00%
1 Month
+14.29%
+14.29%
3 Month
N/A
N/A
6 Month
-66.67%
-66.67%
1 Year
+33.33%
+33.33%

More News

Read More
Lobe Sciences, Ltd. Enters Collaborative Clinical Research Agreement with Integrative Headache Medicine of New York to Study the Effects of L-130 in the Treatment of Chronic Cluster Headache
Via FinancialNewsMedia
Exposures Product Safety
Lobe Sciences Ltd (LOBEF) increases its portfolio with several new chemical entities (NCEs)
Via AB Newswire
Topics Intellectual Property
Exposures Intellectual Property
Lobe Sciences Announces Incorporation of Australian Subsidiary
Via Newsfile
Lobe Sciences Announces Closing of Private Placement
Via Newsfile
Lobe Sciences and Cantheon Capital Enter into Exclusive Investment Agreement to Fund $1.5M USD Toward Clinical Trials in Australia
Via Newsfile
Topics Cannabis
Exposures Cannabis
Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) Featured in Coverage of Planet MicroCap’s Virtual Investor Conference
Via Investor Brand Network
Lobe Sciences Ltd. (OTCQB: LOBEF) (CSE: LOBE) Featured in Coverage of Investor Summit Group’s Q1 Virtual Event
Via Investor Brand Network
Lobe Sciences to Participate at the Advances in Mental Health Psychedelics and Non-Psychedelics Conference
Via Newsfile
Lobe Sciences Provides Corporate Update to Investors and Stakeholders
Via Newsfile
Topics Cannabis Intellectual Property
Exposures COVID-19 Cannabis Intellectual Property
Lobe Sciences to Present At H.C. Wainwright 23rd Annual Global Investment Conference
Via Newsfile
Lobe Sciences Appoints Albert "Skip" Rizzo, Ph.D to Scientific Advisory Board
Via Newsfile
Lobe Sciences Appoints Gilberto Jesús Mendoza, President of the World Boxing Association, to Advisory Board
Via Newsfile
Lobe Sciences Clarifies Recent Promotional Activities at Request of OTC Markets
Via Newsfile
Lobe Sciences Appoints Charles Grob, MD to Scientific Advisory Board
Via Newsfile
Lobe Sciences to Present at H.C. Wainwright Psychedelics in Psychiatry and Beyond Virtual Conference
Via Newsfile
Lobe Sciences to Present at the LD Micro Invitational XI
Via Newsfile
Lobe Sciences Secures Production and Supply Agreement for Vitamind Consumer Packaged Goods Products
Via Newsfile
Lobe Sciences to Present at the Benzinga Global Small Cap Conference
Via Newsfile
Lobe Sciences Acquires Vitamind Line of Wellness Products
Via Newsfile
Topics Intellectual Property
Exposures COVID-19 Intellectual Property
Lobe Sciences Announces Filing of PCT Application
Via Newsfile
Topics Intellectual Property
Exposures Intellectual Property
Lobe Sciences Enters into LOI with Core One Labs to Form a Joint Venture for the Clinical Development of Biosynthetic Psilocybin
Via Newsfile
Lobe Sciences Enters into Joint Venture with Virtual Psychedelics Incorporated to Develop Multi-Sensory Pods for Clinical Psychedelic Use
Via Newsfile
Topics Intellectual Property
Exposures Intellectual Property
Lobe Sciences Appoints Benjamin Kelmendi, MD from Yale University to Scientific Advisory Board
Via Newsfile
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.